Pharming Group (PHAR)
9.34
-0.66
(-6.60%)
USD |
NASDAQ |
May 13, 16:00
Pharming Group Price to Book Value: 3.054 for May 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 13, 2024 | 3.054 |
| May 10, 2024 | 3.27 |
| May 09, 2024 | 3.168 |
| May 08, 2024 | 3.106 |
| May 07, 2024 | 3.159 |
| May 06, 2024 | 3.180 |
| May 03, 2024 | 3.27 |
| May 02, 2024 | 3.27 |
| May 01, 2024 | 3.417 |
| April 30, 2024 | 3.195 |
| April 29, 2024 | 3.241 |
| April 26, 2024 | 3.205 |
| April 25, 2024 | 3.417 |
| April 24, 2024 | 3.214 |
| April 23, 2024 | 3.139 |
| April 22, 2024 | 3.244 |
| April 19, 2024 | 3.27 |
| April 18, 2024 | 3.051 |
| April 17, 2024 | 3.326 |
| April 16, 2024 | 3.326 |
| April 15, 2024 | 3.525 |
| April 12, 2024 | 3.443 |
| April 11, 2024 | 3.695 |
| April 10, 2024 | 3.427 |
| April 09, 2024 | 3.27 |
| Date | Value |
|---|---|
| April 08, 2024 | 3.482 |
| April 05, 2024 | 3.466 |
| April 04, 2024 | 3.496 |
| April 03, 2024 | 3.584 |
| April 02, 2024 | 3.518 |
| April 01, 2024 | 3.690 |
| March 31, 2024 | |
| March 28, 2024 | 3.325 |
| March 27, 2024 | 3.325 |
| March 26, 2024 | 3.328 |
| March 25, 2024 | 3.457 |
| March 22, 2024 | 3.457 |
| March 21, 2024 | 3.374 |
| March 20, 2024 | 3.374 |
| March 19, 2024 | 3.374 |
| March 18, 2024 | 3.527 |
| March 15, 2024 | 3.524 |
| March 14, 2024 | 3.350 |
| March 13, 2024 | 3.408 |
| March 12, 2024 | 3.644 |
| March 11, 2024 | 3.573 |
| March 08, 2024 | 3.529 |
| March 07, 2024 | 3.435 |
| March 06, 2024 | 3.435 |
| March 05, 2024 | 3.423 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.208
Minimum
Jun 16 2022
6.661
Maximum
Dec 23 2020
3.644
Average
3.656
Median
Mar 22 2023
Price to Book Value Benchmarks
| uniQure NV | 1.614 |
| ProQR Therapeutics NV | 4.300 |
| Merus NV | 7.700 |
| argenx SE | 5.214 |
| Pharvaris NV | 2.937 |
Price to Book Value Related Metrics
| PS Ratio | 2.634 |
| PEG Ratio | -0.3503 |
| Price | 9.34 |
| Earnings Yield | -1.71% |
| Market Cap | 628.99M |
| PEGY Ratio | -0.3503 |